Jianfeng Group Lin2016 -026 (Announcement on Foreign Investment of Subsidists)
Release time:
2020-08-05
证券代码:600668 证券简称:尖峰集团 公告编号:2016-026
债券简称:13尖峰01 债券代码:122227
债券简称:13尖峰02 债券代码:122344
浙江尖峰集团股份有限公司
关于子公司对外投资的公告
本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏,并对其内容的真实性、准确性和完整性承担个别及连带责任。
重要内容提示:
l 本公司控股子公司浙江尖峰药业有限公司与德国葛芙制药有限公司、珠海横琴德运嘉国际贸易有限公司签订了《中外合资经营企业合同》,拟在中国浙江省金华市共同出资设立一家中外合资经营企业,致力于建成一个婴幼儿、儿童用药的制药企业。
l 尖峰药业本次拟出资人民币1100万元,占合营公司注册资本的55%。
l 合营公司的成立尚需相关政府商务部门的批准;合营公司成立后的运营团队组织与磨合、产品研发、产品上市销售情况等事项都存在一定的不确定性风险。
一、对外投资概述
(一)2016年7月12日,本公司控股子公司浙江尖峰药业有限公司(以下简称:尖峰药业)与德国葛芙制药有限公司(以下简称:葛芙制药)、珠海横琴德运嘉国际贸易有限公司(以下简称:德运嘉)签订了《中外合资经营企业合同》,合营各方根据平等互利的原则和长期真诚合作的愿望,努力吸取各自专长和采用适宜的先进技术以及科学的管理方法成立合营公司,并致力于建成一个以婴幼儿、儿童用药制剂研发、生产和销售为主的现代化制药企业。
合营公司中文名称是:浙江金得尔儿婴药品有限公司(以下简称“合营公司”)(以工商行政管理部门核定的名称为准)。合营公司的注册资本为人民币2000万元,其中:尖峰药业以现金人民币1100万元出资,葛芙制药以专有技术的知识产权评估作价人民币500万元出资,德运嘉以现金人民币400万元出资。合营公司拟注册在中国浙江省金华市金西开发区。
(二)本次对外投资,尖峰药业的出资金额为人民币1100万元,根据本公司《章程》有关规定,在董事长对外投资审批权限范围之内,无需提交公司董事会、股东大会审议。
(三)该合作事项不属于关联交易,也不构成《上市公司重大资产重组管理办法》规定的重大资产重组情况。
二、协议主题的基本情况
(一)德国葛芙制药有限公司
1、企业名称:德国葛芙制药有限公司(GOHOFF ARZNEIMITTEL GmbH)
2、企业性质:有限责任公司
3、注册地:德国柏林
4、注册日期:2016年3月24日
5、主要办公地点:德国柏林茵塞尔路17号
6、法定代表人:Katharina Bodmeier
7、注册资本:25000欧元
8、主营业务:药品、化学品、化妆品和保健品的开发、销售和贸易
9、主要股东:
|
序号 |
股东名称或姓名 |
出资额(欧元) |
出资比例 |
|
1 |
Prof.Dr.Roland Bodmeier |
12500 |
50% |
|
2 |
FangHuang |
11250 |
45% |
|
3 |
Katharina Bodmeier |
1250 |
5% |
(二)珠海横琴德运嘉国际贸易有限公司
1、企业名称:珠海横琴德运嘉国际贸易有限公司
2、企业性质:有限责任公司(自然人独资)
3、注册地:珠海市横琴新区
4、注册日期:2015年06月17日
5、主要办公地点:珠海市横琴新区宝华路6号105室-3754
6、法定代表人:李华智
7、注册资本:500万元人民币,截止公告日实收资本为240万元。
8、主营业务:从事货物与技术的进出口业务;贸易咨询、技术咨询、技术服务;化妆品及卫生用品进出口批发和零售;非许可类医疗器械经营;医疗用品和器材进出口批发和零售;草药和天然产品的进出口批发和零售;保健食品、乳制品进出口批发和零售;动物用健康食品、保健品和药品的进出口批发和零售;药品进出口批发和零售;预包装食品的批发和销售。
9、主要股东:李华智先生占公司注册资本100%。
10、主要财务指标:截止2015年12月31日,德运嘉的资产总额为27.35万元、资产净额5.93万元、营业收入48.54万元、净利润-4.07万元等;
三、合营公司的基本情况
1、企业名称:浙江金得尔儿婴药品有限公司(以工商行政管理部门核定的名称为准)
2、经营范围:保健品和药品进出口,研究、开发、生产和销售婴幼儿用药及其他生物及化学医药产品。
3、注册资本:2000万元人民币
4、出资方式:尖峰药业以现金出资人民币1100万元,占注册资本的55%;葛芙制药以“地西泮栓”、“对乙酰氨基酚栓”两项专有技术评估作价人民币500万元出资,占注册资本的25%;德运嘉以现金出资人民币400万元出资,占注册资本的20%。
5、董事会安排:合营公司董事会由5名董事组成,尖峰药业委派3人,葛芙制药委派1人,德运嘉委派1人。董事长由尖峰药业委派担任,副董事长由葛芙制药委派。董事长、副董事长和董事的任职期限应为四年。
6、管理层安排:合营公司设总经理1名和财务经理1名。总经理由葛芙制药委派,财务经理由尖峰药业委派,任期为四年。
7、无形资产出资情况:葛芙制药以其拥有的“地西泮栓”、“对乙酰氨基酚栓”两项专有技术作价500万元人民币进行出资。金华金辰资产评估有限公司对上述两项专有技术进行评估并出具了《评估报告》,评估价值为555.00万元(大写人民币伍佰伍拾伍万元)。葛芙制药所拥有的“地西泮栓”、“对乙酰氨基酚栓”两项专有技术不存在抵押、质押或者其他重大争议、诉讼或仲裁事项、查封或者冻结等司法措施。
地西泮栓是用于抗焦虑、睡眠障碍,增加肌肉张力的治疗药物;对乙酰氨基酚是用于感冒或感冒引起的发热,也用于缓解轻至中度疼痛。“地西泮栓”、“对乙酰氨基酚栓”都已经在德国上市。中国国家食品药品监督管理总局的网站显示已经有54个“对乙酰氨基酚栓”的批准文号;尚未有“地西泮栓”的批准文号, 但“地西泮”片剂、注射剂已经有较多的批准文号。合资公司成立后将以上述两项专有技术为基础进行相应产品的研发、经营。
四、合同的主要内容
2016年7月12日,尖峰药业(甲方)、葛芙制药(乙方)和德运嘉(丙方)签订了《中外合资经营企业合同》,主要条款有:
1、甲方、乙方和丙方三方将根据《中华人民共和国中外合资经营企业法》、《中华人民共和国中外合资经营企业法实施条例》等其他与本合同相关的法律、法规和规定,按照平等互利的原则,通过友好协商,一致同意在中国浙江省金华市共同设立中外合资经营企业。
2、合营公司注册资本为人民币2000万元。甲方出资额占注册资本的55%,其中以现金出资人民币1100万元。乙方出资额占注册资本的25%,其中以知识产权出资,以评估作价出资人民币500万元。丙方出资额占注册资本的20%,其中以现金出资人民币400万元。
3、以现金出资时,甲、丙双方应于2017年6月30日前缴付认缴的出资;以知识产权出资时,乙方应在公司成立之日起180工作日内,办理知识产权变更登记,将出资用知识产权所有权和使用权转移至合营公司。
4、合营公司租用甲方拥有的位于金华金西开发区尖峰药业制药基地内厂房。甲方同意该场地可用以建成合营公司的药品研发、生产基地。场地租金须不高于市场价,租赁协议另行签订。租赁期限应为中国法律允许的最长期限20年。
5、董事会是合营公司最高权力机构,合营公司的营业执照颁发之日为其董事会成立之日。合营公司的重大事项应由董事会全体一致决定。对于下列事项应由董事会全体董事一致通过方可做出决定:(1)合营企业章程的修改;(2)合营企业的中止、提前终止、解散、清算或延长合营公司期限;(3)合营企业注册资本的增加和减少;(4)合营企业的合并和分立;(5)合营各方向合营公司外的其他方转让股权。
除上述条款外的其它事项应由多数票通过决议决定,但是至少乙方或丙方委派的一名董事投了赞成票。
6、合营公司设总经理1 名和财务经理1 名。总经理应由乙方委派,财务经理应由甲方委派。他们的任期为四年,同样可根据董事会的决定连任。合营公司的其他高层管理人员,由总经理提议,董事会批准后聘请。
7、合营公司的合营期限为30年,从合营公司营业执照签发之日开始。
8、若合资公司决定解散,需进行清算。在制定和执行清算方案的过程中,清算委员会应尽可能将合营公司的产品、产品开发权益、知识产权、专有技术等分配给乙方和/或丙方。
9、除因不可抗力外,若本合同一方在实质性方面不完整、不恰当履行或终止履行本合同,在收到合营其他方通知后六十天内仍不纠正其违约行为时,该方便构成违约,违约方应承担责任,负责赔偿履约方或合营公司由此遭受的损失,赔偿上限不超过认缴的出资额或以非货币财产出资时的非货币财产。
10、本合同的效力,解释,执行,修改,终止及争议的解决,应适用中国法律。已公布的中国法律未涉及事宜,采用国际惯例。
11、在履行本合同及附件过程中发生的一切争议,各方首先应友好协商解决,如争议各方不能协商解决,则经各方书面同意,可将争议提交中国国际经济贸易仲裁委员会按其仲裁程序进行仲裁。仲裁语言采用中文,翻译成英文。仲裁裁决是终局的,并对各方均有约束力。
12、本合同自合营各方签字盖章,并经有权的审批机构批准后生效。
五、对公司的影响
随着我国人口政策的调整,“全面二胎”政策的实施,预计婴幼儿用药市场将迎来快速增长的机遇,本次尖峰药业通过组建合营公司,引进德国技术开发婴幼儿用药,符合公司的发展战略规划,是公司做大做强医药业务的具体实施。
六、可能存在的风险
本次签署的是《中外合资经营企业合同》,合营公司的成立尚需相关政府商务部门的批准;合营公司成立后的运营团队组织与磨合、产品研发、产品上市销售情况等事项都存在一定的不确定性风险。
敬请广大投资者注意投资风险。
特此公告
浙江尖峰集团股份有限公司董事会
二〇一六年七月十二日
More information
Jingmai Airport Test Flight Successfully Runway Cement Spike Manufacturing
On April 7, a Boeing 737-700 aircraft of China Eastern Airlines Yunnan took off from Kunming. After completing two flight test subjects, it landed safely at Lancang Jingmai Airport. This not only marked the basic completion of the airport flight area, The official start of the test flight also marked that the "Peak" brand airport runway cement passed the first "final exam". Lancang Jingmai Airport is a major project with milestone significance in the history of Pu'er transportation construction. Since then, an air corridor connecting southwest Yunnan and Southeast Asia has been added between Kunming and Pu'er, which will greatly promote the development and utilization of tourism resources in Lancang, Menglian and Ximeng "Pu'er Green Triangle" area, and promote the sustainable development of local economy and society; it is of great significance to strengthen the city's national defense construction, maintain border stability, promote national unity, improve emergency rescue capabilities, and promote Pu'er's integration into the country's "Belt and Road" construction. Since the start of the construction of the airport, Yunnan Jianfeng has been paying close attention to it, organizing technical research and repeated tests, and finally produced high-quality airport runway special cement, and with excellent product quality, superior product performance and high-quality service, it has become a runway for Lancang Airport. Cement manufacturer. This not only fills the gap of "peak" airport special cement, but also is of great significance to promote the "peak" brand and improve the market influence of enterprises. It is understood that Jingmai Airport is initially confirmed to be officially opened to traffic at the end of May. (Li Liangping)
2020
07-31
Jianfeng Pharmaceutical Artificial Niuhuang Project Starts
News from this newspaper Jianfeng Pharmaceutical artificial bezoar technical transformation project recently started construction in Qiubin Factory. Artificial bezoar has the effect of clearing away heat and detoxification, resolving phlegm, and is commonly used in Chinese and Western medicines such as colds, clearing away heat and detoxification. As the vast majority of artificial bezoar-related preparations are national essential drugs, with the further implementation of the medical reform policy, the downstream industry of artificial bezoar will enter a new round of business cycle. Jianfeng Pharmaceutical has many years of experience in artificial bezoar production. The technological transformation project will use the existing workshop structure, public works and operators of Qiubin Factory to achieve an annual production capacity of 100 tons of artificial bezoar by adding production equipment such as double cone rotary vacuum drying, horizontal ball mill pulverizer unit, hopper and hoist, closed screening system, and upgrading some public systems. According to the project implementation plan, the project will complete the civil engineering in May. Complete the commissioning, testing and verification of equipment and facilities in July, with trial production conditions; Strive to complete the on-site inspection of GMP certification before the end of December. At present, the factory buildings in Qiubin are vacated and the site is cleaned up. It is understood that the production of natural bezoar is very small, the price is extremely high, and the market rarely provides it. As a biochemical API, artificial bezoar has fewer manufacturers. In the past, due to relatively loose supervision, the testing methods of raw materials and finished products are relatively simple, the quality control indicators are not perfect, and the quality of products on the market is uneven. It is imperative to improve the quality standards. To this end, the State Food and Drug Administration issued the "Biochemical Drug GMP Quality Management Practice (Draft for Comment)" at the end of 2016, which was implemented in March 2017. spike medicine
2020
07-31
Recently, Jianfeng Health has been awarded a number of plaques and certificates by the Department of Science and Technology of Zhejiang Province, the people's Government of Jinhua City, and the Science and Technology Bureau of Jinhua City. They are "Zhejiang Science and Technology small and medium-sized Enterprises", "Jinhua High-tech Enterprises", "Jinhua Agricultural Science and Technology Enterprises", "Jinhua Agricultural Science and Technology Research and Development Center" and so on. According to the relevant requirements, Zhejiang science and technology-based small and medium-sized enterprises must be small and medium-sized enterprises with independent intellectual property rights, proprietary technology or advanced knowledge, engaged in the research, development, production, sales and service of high-tech and its products, and the proportion of enterprises engaged in scientific and technological research and development personnel accounting for no less than 10% of the total number of employees in that year. Since its establishment, Jianfeng Health has attached great importance to the training of scientific and technological personnel, paid attention to the application of its own intellectual property rights, paid attention to product research and development and the protection of intellectual property rights, promoted the application of intellectual property rights, and encouraged employees to invent and create. By the end of 2016, a total of 8 invention patents and 5 appearance patents had been applied, and 1 invention patent and 5 appearance patents had been obtained. High-tech enterprises in Jinhua City must meet the requirements of the ''High-tech Fields Supported by the State, ''and continue to carry out research and development and technological achievements transformation. Their main products (services) have independent intellectual property rights (authorized, registered or accepted). There are certain requirements for the proportion of R & D personnel, the proportion of R & D funds and the income of high-tech products. The acquisition of high-tech enterprises in Jinhua City has laid the foundation for the further declaration of national high-tech enterprises in the future. In the identification of agricultural science and technology enterprises in Jinhua City, the field of peak health technology belongs to the deep processing technology and equipment of agricultural products, Chinese herbal pieces and plant extracts.
2020
07-31
Jingmai Airport Test Flight Successfully Runway Cement Spike Manufacturing
On April 7, a Boeing 737-700 aircraft of China Eastern Airlines Yunnan took off from Kunming. After completing two flight test subjects, it landed safely at Lancang Jingmai Airport. This not only marked the basic completion of the airport flight area, The official start of the test flight also marked that the "Peak" brand airport runway cement passed the first "final exam". Lancang Jingmai Airport is a major project with milestone significance in the history of Pu'er transportation construction. Since then, an air corridor connecting southwest Yunnan and Southeast Asia has been added between Kunming and Pu'er, which will greatly promote the development and utilization of tourism resources in Lancang, Menglian and Ximeng "Pu'er Green Triangle" area, and promote the sustainable development of local economy and society; it is of great significance to strengthen the city's national defense construction, maintain border stability, promote national unity, improve emergency rescue capabilities, and promote Pu'er's integration into the country's "Belt and Road" construction. Since the start of the construction of the airport, Yunnan Jianfeng has been paying close attention to it, organizing technical research and repeated tests, and finally produced high-quality airport runway special cement, and with excellent product quality, superior product performance and high-quality service, it has become a runway for Lancang Airport. Cement manufacturer. This not only fills the gap of "peak" airport special cement, but also is of great significance to promote the "peak" brand and improve the market influence of enterprises. It is understood that Jingmai Airport is initially confirmed to be officially opened to traffic at the end of May. (Li Liangping)
2020
07-30
Peak Pharmaceutical was rated as a national intellectual property advantage enterprises
The score ranked first among Jinhua participating enterprises. A few days ago, Peak Pharmaceutical Company was rated as a national intellectual property advantage enterprise. The selection of national intellectual property advantage enterprises is organized by the State Intellectual Property Office. The purpose is to accelerate the formation of a group of Chinese intellectual property leading enterprises with independent intellectual property rights, well-known brands and international competitive advantages, and achieve the development goal of strong intellectual property enterprises. Since Jianfeng Pharmaceutical introduced the GB-T29490-2013 "Enterprise Intellectual Property Management Standard" in 2013, it has been rated as a patent demonstration enterprise in Zhejiang Province in 2013. In 2014, the "Jianfeng" trademark obtained a famous trademark in Zhejiang Province, and the first edition of the "Intellectual Property Manual" was compiled and implemented in 2015. In 2016, it passed the third-party certification of the GB-T29490-2013 "Enterprise Intellectual Property Management Standard". The "Jianfeng" trademark was rated as a well-known trademark by the State Administration of China. In the application and selection of national knowledge by superior enterprises, 52 enterprises in Zhejiang Province won this honor, ranking second in the country in number; Jianfeng Pharmaceutical ranked first among Jinhua participating enterprises. (Zhang Mingyin)
2020
07-31
Group Party Committee to determine the annual work plan
The party Committee of the group company has determined its work ideas and work plan for 2017 a few days ago, and relevant work has been arranged below. In view of the current new political and economic situation and the task of enterprise transformation and development, the general requirements of the Party Committee of the Group Company for 2017 are: to thoroughly study and implement the spirit of the Sixth Plenary Session of the 18th CPC Central Committee and the series of important speeches by General Secretary Xi Jinping, the spirit of the Seventh Party Congress of Jinhua City, to closely revolve around the center of enterprise production, operation and reform and development, and to adhere to scientific development and cross-regional development as the first priority, in order to continue to carry out the study and education of "five stars striving for innovation" and "two learning and one doing", we should highlight the main line of comprehensively and strictly administering the party according to the rules, firmly establish the political consciousness, overall situation consciousness, core consciousness and alignment consciousness of the majority of Party members and cadres, strengthen and improve the party building work in enterprises in the spirit of reform, and strive to improve the scientific, standardized and institutionalized level of Party building work in enterprises, in order to promote the scientific development of the group company, leapfrog development and harmonious development, it provides a strong political, ideological and organizational guarantee. The working idea of the Party Committee of the Group Company in 2017 is to focus on "one center", adhere to "one concept", highlight "three key points" and do a good job in "three constructions". That is: centering on the "one center" of enterprise production, operation and reform and development, we should strive to strengthen the "one concept" of "the organic unity of the party's leadership and the improvement of corporate governance"; to "thoroughly implement the main responsibility of the party committee; continue to carry out the study and education of" two learning and one doing "; and improve the system of party building work" as the "three key points", and focus on "team building and team building
2020
07-31